Growth Metrics

Medpace Holdings (MEDP) Cash from Financing Activities (2016 - 2026)

Medpace Holdings filings provide 12 years of Cash from Financing Activities readings, the most recent being $12.7 million for Q1 2026.

  • On a quarterly basis, Cash from Financing Activities rose 103.66% to $12.7 million in Q1 2026 year-over-year; TTM through Mar 2026 was -$501.8 million, a 1.16% increase, with the full-year FY2025 number at -$860.4 million, down 458.66% from a year prior.
  • Cash from Financing Activities hit $12.7 million in Q1 2026 for Medpace Holdings, down from $22.7 million in the prior quarter.
  • In the past five years, Cash from Financing Activities ranged from a high of $22.7 million in Q4 2025 to a low of -$540.6 million in Q2 2025.
  • Median Cash from Financing Activities over the past 5 years was -$52.7 million (2023), compared with a mean of -$115.3 million.
  • Biggest five-year swings in Cash from Financing Activities: skyrocketed 114.54% in 2024 and later tumbled 81265.77% in 2025.
  • Medpace Holdings' Cash from Financing Activities stood at -$131.1 million in 2022, then surged by 101.16% to $1.5 million in 2023, then crashed by 11170.85% to -$168.6 million in 2024, then soared by 113.48% to $22.7 million in 2025, then crashed by 44.26% to $12.7 million in 2026.
  • The last three reported values for Cash from Financing Activities were $12.7 million (Q1 2026), $22.7 million (Q4 2025), and $3.4 million (Q3 2025) per Business Quant data.